Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04633551 · ClinicalTrials.gov registry record · NA
Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04633551: Completed NA study, sponsored by University of South Carolina.
NCT04633551 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04633551, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Women who had an adverse pregnancy outcome (APO), such as preeclampsia, preterm birth, or gestational diabetes, have a higher risk for heart disease. Some of the extra risk for heart disease after APOs is thought to be caused by inflammation. Investigators will randomize women who had an APO in the past 3 years to receive an anti-inflammatory supplement or serve as a time control. Investigators will compare blood pressure, arterial stiffness, blood vessel reactivity, and blood markers of inflammation between women who did and did not receive the supplement. Investigators will determine women's attitudes about taking a dietary supplement and measure whether the participants who receive the supplement take all or most of the doses.
Primary Outcome
Investigators will measure blood pressure in the arm and use applanation tonometry to estimate aortic blood pressure
Interventions
- DIETARY_SUPPLEMENT Anti-inflammatory supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2022-05-30 |
| Phase | NA |
What the finished NCT04633551 record still lists
NCT04633551 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Anti-inflammatory supplement is the first listed.
NCT04633551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04633551 about?
NCT04633551 is a clinical study titled "Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes". Women who had an adverse pregnancy outcome (APO), such as preeclampsia, preterm birth, or gestational diabetes, have a higher risk for heart disease. Some of the extra risk for heart disease after APOs is thought to be caused by inflammation. Investigators will randomize women who had an APO in the ...
What is the current status of trial NCT04633551?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2020-10-01. Estimated completion is 2022-05-30.
What interventions are being tested in trial NCT04633551?
The interventions under investigation include: Anti-inflammatory supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04633551?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04633551's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI